{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:02:51Z","timestamp":1781553771942,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Science and Technology Xingwei Youth projects of Suzhou","award":["KJXW2021062"],"award-info":[{"award-number":["KJXW2021062"]}]},{"name":"the Science and Technology Youth projects of Zhang Jiagang","award":["ZJGQNKJ202201"],"award-info":[{"award-number":["ZJGQNKJ202201"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Metformin, a first-line drug used to treat type 2 diabetes mellitus (T2DM), also reduces neuroinflammation and improves motor and cognitive outcomes. Metformin binds to presenilin enhancer 2 (PEN2) and further enhances its therapeutic benefits. The mechanisms of HIV-associated neurocognitive disorders (HANDs) remain unclear. HIV-1 trans-activator of transcription (Tat) contributes to neurotoxicity in HAND. We revealed that PEN2 expression decreased markedly in HAND patients and Tat-infected microglia. Metformin (200\u00a0\u00b5M) treatment significantly reduced Tat-induced decreases in cell viability, oxidative stress, the proinflammatory response and excessive glutamate and iNOS release and had neuroprotective effects. Tat subsequently increased NF-\u03baB activity, which was prominently suppressed during treatment. In addition, PEN2 knockdown in microglia dramatically reversed the neuroprotective effect of metformin against Tat. Our findings indicate that metformin binds PEN2 and modulates microglia-mediated HIV-1 Tat neurotoxicity in HAND.<\/jats:p>","DOI":"10.1007\/s13365-025-01263-w","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T10:09:52Z","timestamp":1749031792000},"page":"376-388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metformin promotes PEN2 expression to attenuate microglia-mediated neurotoxicity induced by HIV-1 Tat"],"prefix":"10.1007","volume":"31","author":[{"given":"Ya","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yezi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"1263_CR1","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1007\/s12640-021-00417-y","volume":"39","author":"M Abdi","year":"2021","unstructured":"Abdi M et al (2021) Metformin therapy attenuates pro-inflammatory microglia by inhibiting NF-kappaB in cuprizone demyelinating mouse model of multiple sclerosis. Neurotox Res 39:1732\u20131746. https:\/\/doi.org\/10.1007\/s12640-021-00417-y","journal-title":"Neurotox Res"},{"key":"1263_CR2","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cmet.2016.05.011","volume":"23","author":"N Barzilai","year":"2016","unstructured":"Barzilai N et al (2016) Metformin as a tool to target aging. Cell Metab 23:1060\u20131065. https:\/\/doi.org\/10.1016\/j.cmet.2016.05.011","journal-title":"Cell Metab"},{"key":"1263_CR3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/brain\/awy339","volume":"142","author":"L Bertrand","year":"2019","unstructured":"Bertrand L, Cho HJ, Toborek M (2019) Blood-brain barrier pericytes as a target for HIV-1 infection. Brain 142:502\u2013511. https:\/\/doi.org\/10.1093\/brain\/awy339","journal-title":"Brain"},{"key":"1263_CR4","doi-asserted-by":"publisher","first-page":"e1002213","DOI":"10.1371\/journal.ppat.1002213","volume":"7","author":"A Borjabad","year":"2011","unstructured":"Borjabad A et al (2011) Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders. PLoS Pathog 7:e1002213. https:\/\/doi.org\/10.1371\/journal.ppat.1002213","journal-title":"PLoS Pathog"},{"key":"1263_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/07853890.2020.1814962","volume":"53","author":"A Borrajo","year":"2021","unstructured":"Borrajo A et al (2021) Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis. Ann Med 53:43\u201369. https:\/\/doi.org\/10.1080\/07853890.2020.1814962","journal-title":"Ann Med"},{"key":"1263_CR6","doi-asserted-by":"publisher","first-page":"4196572","DOI":"10.1155\/2016\/4196572","volume":"2016","author":"Y Chen","year":"2016","unstructured":"Chen Y et al (2016) HIV-1 tat regulates occludin and abeta transfer receptor expression in brain endothelial cells via Rho\/ROCK signaling pathway. Oxid Med Cell Longev 2016:4196572. https:\/\/doi.org\/10.1155\/2016\/4196572","journal-title":"Oxid Med Cell Longev"},{"key":"1263_CR7","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1523\/JNEUROSCI.3045-16.2017","volume":"37","author":"ET Chivero","year":"2017","unstructured":"Chivero ET et al (2017) HIV-1 Tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation. J Neurosci 37:3599\u20133609. https:\/\/doi.org\/10.1523\/JNEUROSCI.3045-16.2017","journal-title":"J Neurosci"},{"key":"1263_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.mpmed.2022.01.002","volume":"50","author":"V Delpech","year":"2022","unstructured":"Delpech V (2022) The HIV epidemic: global and United Kingdom trends. Medicine (Abingdon) 50:202\u2013204. https:\/\/doi.org\/10.1016\/j.mpmed.2022.01.002","journal-title":"Medicine (Abingdon)"},{"key":"1263_CR9","doi-asserted-by":"publisher","first-page":"113310","DOI":"10.1016\/j.expneurol.2020.113310","volume":"329","author":"NA Devanney","year":"2020","unstructured":"Devanney NA, Stewart AN, Gensel JC (2020) Microglia and macrophage metabolism in CNS injury and disease: The role of immunometabolism in neurodegeneration and neurotrauma. Exp Neurol 329:113310. https:\/\/doi.org\/10.1016\/j.expneurol.2020.113310","journal-title":"Exp Neurol"},{"key":"1263_CR10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41574-019-0242-2","volume":"15","author":"M Foretz","year":"2019","unstructured":"Foretz M, Guigas B, Viollet B (2019) Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nat Rev Endocrinol 15:569\u2013589. https:\/\/doi.org\/10.1038\/s41574-019-0242-2","journal-title":"Nat Rev Endocrinol"},{"key":"1263_CR11","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.3390\/ijms25074083","volume":"25","author":"MA Galal","year":"2024","unstructured":"Galal MA et al (2024) Metformin: a dual-role player in cancer treatment and prevention. Int J Mol Sci 25:4083. https:\/\/doi.org\/10.3390\/ijms25074083","journal-title":"Int J Mol Sci"},{"key":"1263_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/01.aids.0000432467.54003.f7","volume":"28","author":"LJ Garvey","year":"2014","unstructured":"Garvey LJ et al (2014) Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART. AIDS 28:67\u201372. https:\/\/doi.org\/10.1097\/01.aids.0000432467.54003.f7","journal-title":"AIDS"},{"key":"1263_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s13365-021-01049-w","volume":"28","author":"SBH Gumbs","year":"2022","unstructured":"Gumbs SBH et al (2022) Human microglial models to study HIV infection and neuropathogenesis: a literature overview and comparative analyses. J Neurovirol 28:64\u201391. https:\/\/doi.org\/10.1007\/s13365-021-01049-w","journal-title":"J Neurovirol"},{"key":"1263_CR14","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","volume":"75","author":"RK Heaton","year":"2010","unstructured":"Heaton RK et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087\u20132096. https:\/\/doi.org\/10.1212\/WNL.0b013e318200d727","journal-title":"Neurology"},{"key":"1263_CR15","doi-asserted-by":"publisher","first-page":"1267041","DOI":"10.1155\/2021\/1267041","volume":"2021","author":"S Jadhav","year":"2021","unstructured":"Jadhav S, Nema V (2021) HIV-associated neurotoxicity: the interplay of host and viral proteins. Mediat Inflamm 2021:1267041. https:\/\/doi.org\/10.1155\/2021\/1267041","journal-title":"Mediat Inflamm"},{"key":"1263_CR16","doi-asserted-by":"publisher","first-page":"3160360","DOI":"10.1155\/2017\/3160360","volume":"2017","author":"W Jiang","year":"2017","unstructured":"Jiang W et al (2017) HIV-1 transactivator protein induces ZO-1 and neprilysin dysfunction in brain endothelial cells via the ras signaling pathway. Oxid Med Cell Longev 2017:3160360. https:\/\/doi.org\/10.1155\/2017\/3160360","journal-title":"Oxid Med Cell Longev"},{"key":"1263_CR17","doi-asserted-by":"publisher","first-page":"e13277","DOI":"10.1111\/acel.13277","volume":"20","author":"M Kodali","year":"2021","unstructured":"Kodali M et al (2021) Metformin treatment in late middle age improves cognitive function with alleviation of microglial activation and enhancement of autophagy in the hippocampus. Aging Cell 20:e13277. https:\/\/doi.org\/10.1111\/acel.13277","journal-title":"Aging Cell"},{"key":"1263_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/pnasnexus\/pgae179","volume":"3","author":"W Kong","year":"2024","unstructured":"Kong W et al (2024) Neuroinflammation generated by HIV-infected microglia promotes dysfunction and death of neurons in human brain organoids. PNAS Nexus 3:179. https:\/\/doi.org\/10.1093\/pnasnexus\/pgae179","journal-title":"PNAS Nexus"},{"issue":"2","key":"1263_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00210-009-0477-x","volume":"381","author":"K Labuzek","year":"2010","unstructured":"Labuzek K, Liber S, Gabryel B, Adamczyk J, Okopie\u0144 B (2010) Metformin increases phagocytosis and acidifies lysosomal\/endosomal compartments in AMPK-dependent manner in rat primary microglia. Naunyn Schmiedebergs Arch Pharmacol 381(2):171\u2013186. https:\/\/doi.org\/10.1007\/s00210-009-0477-x","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1263_CR20","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.pbb.2012.03.002","volume":"101","author":"J Li","year":"2012","unstructured":"Li J et al (2012) Metformin attenuates Alzheimer\u2019s disease-like neuropathology in obese, leptin-resistant mice. Pharmacol Biochem Behav 101:564\u2013574. https:\/\/doi.org\/10.1016\/j.pbb.2012.03.002","journal-title":"Pharmacol Biochem Behav"},{"key":"1263_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","volume":"603","author":"T Ma","year":"2022","unstructured":"Ma T et al (2022) Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature 603:159\u2013165. https:\/\/doi.org\/10.1038\/s41586-022-04431-8","journal-title":"Nature"},{"key":"1263_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2174\/1389450116666150626124544","volume":"17","author":"MK Mamik","year":"2016","unstructured":"Mamik MK, Ghorpade A (2016) CXCL8 as a potential therapeutic target for HIV-associated neurocognitive disorders. Curr Drug Targets 17:111\u2013121. https:\/\/doi.org\/10.2174\/1389450116666150626124544","journal-title":"Curr Drug Targets"},{"key":"1263_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11481-016-9708-3","volume":"12","author":"MK Mamik","year":"2017","unstructured":"Mamik MK et al (2017) HIV-1 viral protein R activates NLRP3 inflammasome in microglia: implications for HIV-1 associated neuroinflammation. J Neuroimmune Pharmacol 12:233\u2013248. https:\/\/doi.org\/10.1007\/s11481-016-9708-3","journal-title":"J Neuroimmune Pharmacol"},{"key":"1263_CR24","doi-asserted-by":"publisher","first-page":"e0130189","DOI":"10.1371\/journal.pone.0130189","volume":"10","author":"G Mangino","year":"2015","unstructured":"Mangino G et al (2015) HIV-1 myristoylated nef treatment of murine microglial cells activates inducible nitric oxide synthase, NO2 production and neurotoxic activity. PLoS ONE 10:e0130189. https:\/\/doi.org\/10.1371\/journal.pone.0130189","journal-title":"PLoS ONE"},{"key":"1263_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fnagi.2020.00168","volume":"12","author":"J Marino","year":"2020","unstructured":"Marino J, Wigdahl B, Nonnemacher MR (2020) Extracellular HIV-1 tat mediates increased glutamate in the CNS leading to onset of senescence and progression of HAND. Front Aging Neurosci 12:168. https:\/\/doi.org\/10.3389\/fnagi.2020.00168","journal-title":"Front Aging Neurosci"},{"key":"1263_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/tra.12578","author":"AR Mele","year":"2018","unstructured":"Mele AR et al (2018) Defining the molecular mechanisms of HIV-1 Tat secretion: PtdIns(4,5)P(2) at the epicenter. Traffic. https:\/\/doi.org\/10.1111\/tra.12578","journal-title":"Traffic"},{"key":"1263_CR27","doi-asserted-by":"publisher","first-page":"742065","DOI":"10.1038\/s41392-023-01588-0","volume":"15","author":"L Muzio","year":"2021","unstructured":"Muzio L, Viotti A, Martino G (2021) Microglia in neuroinflammation and neurodegeneration: from understanding to therapy. Front Neurosci 15:742065. https:\/\/doi.org\/10.1038\/s41392-023-01588-0","journal-title":"Front Neurosci"},{"key":"1263_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s12011-023-03667-3","volume":"202","author":"A Oruc","year":"2024","unstructured":"Oruc A et al (2024) The role of glycogen synthase kinase-3beta in the Zinc-mediated neuroprotective effect of metformin in rats with glutamate neurotoxicity. Biol Trace Elem Res 202:233\u2013245. https:\/\/doi.org\/10.1007\/s12011-023-03667-3","journal-title":"Biol Trace Elem Res"},{"key":"1263_CR29","doi-asserted-by":"publisher","first-page":"108903","DOI":"10.1016\/j.intimp.2022.108903","volume":"109","author":"L Peng","year":"2022","unstructured":"Peng L et al (2022) Metformin alleviates prolonged isoflurane inhalation induced cognitive decline via reducing neuroinflammation in adult mice. Int Immunopharmacol 109:108903. https:\/\/doi.org\/10.1016\/j.intimp.2022.108903","journal-title":"Int Immunopharmacol"},{"key":"1263_CR30","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.bbi.2019.03.011","volume":"80","author":"P Periyasamy","year":"2019","unstructured":"Periyasamy P et al (2019) HIV-1 Tat-mediated microglial inflammation involves a novel miRNA-34a-NLRC5-NFkappaB signaling axis. Brain Behav Immun 80:227\u2013237. https:\/\/doi.org\/10.1016\/j.bbi.2019.03.011","journal-title":"Brain Behav Immun"},{"key":"1263_CR31","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","volume":"60","author":"G Rena","year":"2017","unstructured":"Rena G, Hardie DG, Pearson ER (2017) The mechanisms of action of metformin. Diabetologia 60:1577\u20131585. https:\/\/doi.org\/10.1007\/s00125-017-4342-z","journal-title":"Diabetologia"},{"key":"1263_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1750-1326-9-26","volume":"9","author":"V Repunte-Canonigo","year":"2014","unstructured":"Repunte-Canonigo V et al (2014) Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats. Mol Neurodegener 9:26. https:\/\/doi.org\/10.1186\/1750-1326-9-26","journal-title":"Mol Neurodegener"},{"key":"1263_CR33","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3390\/cells8101245","volume":"8","author":"V Rojas-Celis","year":"2019","unstructured":"Rojas-Celis V et al (2019) New challenges of HIV-1 infection: how HIV-1 attacks and resides in the central nervous system. Cells 8:1245. https:\/\/doi.org\/10.3390\/cells8101245","journal-title":"Cells"},{"key":"1263_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fpsyt.2016.00102","volume":"7","author":"SA Rowson","year":"2016","unstructured":"Rowson SA et al (2016) Neuroinflammation and behavior in HIV-1 transgenic rats exposed to chronic adolescent stress. Front Psychiatry 7:102. https:\/\/doi.org\/10.3389\/fpsyt.2016.00102","journal-title":"Front Psychiatry"},{"key":"1263_CR35","doi-asserted-by":"publisher","first-page":"8408","DOI":"10.1523\/JNEUROSCI.2851-18.2019","volume":"39","author":"W Ru","year":"2019","unstructured":"Ru W et al (2019) Microglia mediate HIV-1 gp120-induced synaptic degeneration in spinal pain neural circuits. J Neurosci 39:8408\u20138421. https:\/\/doi.org\/10.1523\/JNEUROSCI.2851-18.2019","journal-title":"J Neurosci"},{"key":"1263_CR36","doi-asserted-by":"publisher","first-page":"eaax1912","DOI":"10.1126\/sciadv.aax1912","volume":"5","author":"RM Ruddy","year":"2019","unstructured":"Ruddy RM, Adams KV, Morshead CM (2019) Age- and sex-dependent effects of metformin on neural precursor cells and cognitive recovery in a model of neonatal stroke. Sci Adv 5:eaax1912. https:\/\/doi.org\/10.1126\/sciadv.aax1912","journal-title":"Sci Adv"},{"key":"1263_CR37","doi-asserted-by":"publisher","first-page":"a007120","DOI":"10.1101\/cshperspect.a007120","volume":"2","author":"S Spudich","year":"2012","unstructured":"Spudich S, Gonzalez-Scarano F (2012) HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment. Cold Spring Harb Perspect Med 2:a007120. https:\/\/doi.org\/10.1101\/cshperspect.a007120","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1263_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12035-019-01709-3","volume":"56","author":"M Stenovec","year":"2019","unstructured":"Stenovec M et al (2019) Slow release of HIV-1 protein nef from vesicle-like structures is inhibited by cytosolic calcium elevation in single human microglia. Mol Neurobiol 56:102\u2013118. https:\/\/doi.org\/10.1007\/s12035-019-01709-3","journal-title":"Mol Neurobiol"},{"key":"1263_CR39","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.3390\/ijms25094697","volume":"25","author":"LJ Thompson","year":"2024","unstructured":"Thompson LJ et al (2024) HIV-associated neurocognitive disorder: a look into cellular and molecular pathology. Int J Mol Sci 25:4697. https:\/\/doi.org\/10.3390\/ijms25094697","journal-title":"Int J Mol Sci"},{"key":"1263_CR40","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.bbrc.2020.10.075","volume":"534","author":"G Wang","year":"2021","unstructured":"Wang G et al (2021) Metformin alleviates high glucose-induced ER stress and inflammation by inhibiting the interaction between caveolin1 and AMPKalpha in rat astrocytes. Biochem Biophys Res Commun 534:908\u2013913. https:\/\/doi.org\/10.1016\/j.bbrc.2020.10.075","journal-title":"Biochem Biophys Res Commun"},{"key":"1263_CR41","doi-asserted-by":"publisher","first-page":"581346","DOI":"10.3389\/fneur.2020.581346","volume":"11","author":"J Wei","year":"2020","unstructured":"Wei J et al (2020) The prevalence of frascati-criteria-based HIV-associated neurocognitive disorder (HAND) in HIV-infected adults: a systematic review and meta-analysis. Front Neurol 11:581346. https:\/\/doi.org\/10.3389\/fneur.2020.581346","journal-title":"Front Neurol"},{"key":"1263_CR42","doi-asserted-by":"publisher","first-page":"104701","DOI":"10.1016\/j.nbd.2019.104701","volume":"136","author":"ME Williams","year":"2020","unstructured":"Williams ME et al (2020) Signatures of HIV-1 subtype B and C Tat proteins and their effects in the neuropathogenesis of HIV-associated neurocognitive impairments. Neurobiol Dis 136:104701. https:\/\/doi.org\/10.1016\/j.nbd.2019.104701","journal-title":"Neurobiol Dis"},{"key":"1263_CR43","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1007\/s12035-016-9895-1","volume":"54","author":"D Zhang","year":"2017","unstructured":"Zhang D et al (2017) Metformin improves functional recovery after spinal cord injury via autophagy flux stimulation. Mol Neurobiol 54:3327\u20133341. https:\/\/doi.org\/10.1007\/s12035-016-9895-1","journal-title":"Mol Neurobiol"},{"key":"1263_CR44","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.1523\/JNEUROSCI.0061-08.2008","volume":"28","author":"Y Zhong","year":"2008","unstructured":"Zhong Y et al (2008) Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling. J Neurosci 28:7788\u20137796. https:\/\/doi.org\/10.1523\/JNEUROSCI.0061-08.2008","journal-title":"J Neurosci"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-025-01263-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13365-025-01263-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-025-01263-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T12:55:01Z","timestamp":1758200101000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13365-025-01263-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1263"],"URL":"https:\/\/doi.org\/10.1007\/s13365-025-01263-w","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}